Open access · OA
via Europe PMC
Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening
Authors not listed
Innovation in aging · 2025
Abstract
A 2025 multi-omics study in *Innovation in Aging* identifies mTOR(definition) inhibitors as potential targeted treatments for vascular aging in progeria.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2025). Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC12761944
Vancouver
Anonymous. Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening. Innovation in aging. 2025.
BibTeX
@article{anon2025Target,
title = {Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening},
author = {Anonymous},
journal = {Innovation in aging},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Aging 2023
Open access · OA
Targeting the biology of aging with mTOR inhibitors
EMBO Reports 2023
Preprint · OA
Lysosomes in senescence and aging
Vitamins and hormones 2021
Citation only
Aging and FGF23-klotho system
Trends in Endocrinology and Metabolism 2023
Citation only
The ticking of aging clocks
Journal of the American College of Cardiology 2017
Open access · OA
The Aging Cardiovascular System
Cell 2001
Open access · OA